Accuray Incorporated Stock Prediction
AI-powered sentiment analysis and prediction trends for ARAY, updated each market day.
ARAY AI Sentiment
AI sees no strong directional signal for Accuray Incorporated stock over the next 10 market days.
Prediction date: Sept. 21, 2026
Exact scores are in the SharePreds app
The precise prediction score for this stock, with buy and sell targets and a stop loss, updated every market day.
About Accuray Incorporated
Accuray Inc is a radiation oncology company that develops, manufactures, sells and supports precise, treatment solutions which set the standard of radiation therapy care with the objective of helping patients live lives. The company's technology, The CyberKnife, is used to treat multiple types of cancer and tumors throughout the body. The CyberKnife Systems automatically track, detect and correct for a tumor and patient movement in real-time during the procedure, enabling delivery of precise, high dose radiation with sub-millimetre accuracy while patients breathe normally, without manual user intervention. The company has one operating segment which develops, manufactures and markets proprietary medical devices used in radiation therapy for the treatment of cancer patients.
Sector
Exchange
Market Cap
$28,784,872
Cap Tier
Employees
809
Headquarters
MADISON, WI
Listed Since
Feb. 8, 2007
Website
ARAY Sentiment Trend: Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
ARAY Volatility
Accuray Incorporated has shown high price volatility over the last 5 trading days. High volatility means larger price swings: this can present both opportunity and risk for traders.
